The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1334
Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation
The full article is available to subscribers Subscriber Login   
Revised 4/13/10: The last sentence of the Dosage, Administration and Cost paragraph should have listed the cost of 1 gram of sodium ferric gluconate (Ferrlecit) as about $600.

Revised 4/24/15: Since this article was published, new information about the risk of anaphylaxis has become available. http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Ferumoxytol (Fer yoo mox’ i tole; Feraheme – AMAG), an intravenous (IV) iron replacement product, has been approved by the FDA for treatment of iron deficiency anemia in adults with chronic kidney disease. Iron deficiency anemia is common in chronic kidney disease and may be associated with decreased absorption from the gastrointestinal tract, limiting the usefulness of oral iron replacement. IV iron replacement can lower the dose requirement for erythropoiesis-stimulating drugs, particularly in patients on dialysis.1

IV IRON FORMULATIONS — Four other FDA-approved injectable iron products are already available in the US: high molecular weight iron dextran (Dexferrum), low molecular weight iron dextran (INFeD), sodium ferric gluconate (Ferrlecit), and iron sucrose (Venofer). High molecular weight iron dextran has been associated with a high incidence of ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation
Article code: 1334c
 Electronic, downloadable article - $25